Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor Spi-B (SPIB) is an ETS family protein acting as a DNA-binding transcriptional activator within lymphoid lineages. It is critical for the development, structural maturation, and antigen-uptake function of specialized immune cells called M cells in the gut, and plays a key role in B cell differentiation[1][3]. In cancer, SPIB can activate key signaling pathways (NFkB, JNK) as part of its tumor suppressor activity[5]. Dysfunction or deficiency of Spi-B affects immune responses, host-microbe interactions, and tumor suppression, making it a molecular target of interest in immunology and oncology[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor Spi-B (SPIB).